Genmab A (GMAB) Gross Margin (2024 - 2026)

Genmab A's (GMAB) quarterly Gross Margin came in at 92.75% in Q1 2026, down 138.0% YoY from 244.07% in Q1 2025, and down 1.44% on a QoQ basis from 94.1% in Q3 2025.

Genmab A (GMAB) Gross Margin (2024 - 2026) Analysis & Trends

Genmab A (GMAB) has 3 years of Gross Margin data on file, last reported at 92.75% in Q1 2026.

  • Quarterly Gross Margin fell 138.0% year-over-year to 92.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 93.86% (down 167.0% YoY) and the FY2025 annual result came in at 93.6%, down 182.0% from the prior year.
  • Gross Margin retreated to 92.75% in Q1 2026, from 94.1% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 96.02% in Q2 2024 to a low of 92.75% in Q1 2026.
  • A 3-year average of 94.59% and a median of 94.13% in 2025 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2025 — Gross Margin sank 206 bps — and 2026, when it plunged 138 bps.
  • Tracing GMAB's Gross Margin over 3 years: stood at 95.68% in 2024, then decreased by 2 bps to 94.1% in 2025, then slipped by 1 bps to 92.75% in 2026.
  • The last three Gross Margin figures came in at 92.75% (Q1 2026), 94.1% (Q3 2025), and 93.96% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Genmab A 2.05 Bn 548.77 Mn 1.07 Bn 92.73%

Historic Data

Download Data
DateValue
Jun 30, 2026 92.73%
Mar 31, 2026 92.75%
Sep 30, 2025 94.10%
Jun 30, 2025 93.96%
Mar 31, 2025 94.13%
Sep 30, 2024 95.68%
Jun 30, 2024 96.02%
Mar 31, 2024 95.52%